Showing 1241-1250 of 1717 results for "".
News
https://practicalneurology.com/columns/practice-management/news/30537/Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-making-progress-for-more-accurate-diagnoses-and-targeted-treatments/32114/Advances in testing and treatments for myasthenia gravis are leading to more accurate diagnoses and improvements in symptom control for individuals with this rare chronic autoimmune disease.Immunomodulation for Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immunomodulation-for-parkinson-disease/31827/Multiple immunomodulators are being evaluated for potential treatment of Parkinson disease.Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.Behavioral and Integrative Therapies for Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/behavioral-and-integrative-therapies-for-headache/31518/Many patients who may benefit from these treatments may not be aware nonpharmacologic approaches exist.A Neurologic Assessment of The Salem Witch Trials
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-neurologic-assessment-of-the-salem-witch-trials-1/35450/In the Salem witch trials, which led to the deaths of 25 innocent people, a combination of political, religious, social, and medical factors triggered mass panic, spurred on by the symptoms of 5 young women who likely had a functional neurologic disorder.Stroke Snapshot: Acute Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-acute-ischemic-stroke/31855/Advances in stroke care are abundant.